Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV

Among people with HIV (PWH), COVID-19 is common and potentially severe. We leveraged REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) to assess the effects of statin therapy for cardiovascular disease prevention on COVID-19 outcomes (incidence and serious cases) among a global cohort of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Open Forum Infectious Diseases 2024-10, Vol.11 (10), p.ofae574
Hauptverfasser:	Zanni, Markella V, Umbleja, Triin, Fichtenbaum, Carl J, Fitch, Kathleen V, McCallum, Sara, Aberg, Judith A, Overton, Edgar Turner, Malvestutto, Carlos D, Bloomfield, Gerald S, Currier, Judith S, Schnittman, Samuel R, Erlandson, Kristine M, Diggs, Marissa R, Foldyna, Borek, Martinez, Esteban, Somboonwit, Charurut, Wang, Gary P, Mushatt, David, Connick, Elizabeth, Lu, Michael T, Douglas, Pamela S, Ribaudo, Heather J, Grinspoon, Steven K
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular agents Cardiovascular diseases Care and treatment Clinical Trials and Therapeutics HIV (Viruses) HIV patients Statins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!